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Aim: A large inter-subject variability in the blood pressure (BP) response to glucose drinks
has been reported. However, the underlying factors remain elusive and we hypothesized
that accompanying changes in glucose metabolism affect these BP responses.
Methods: Cardiovascular and glycemic changes in response to a standard
75 g oral-glucose-tolerance-test were investigated in 30 healthy, non-obese
males. Continuous cardiovascular monitoring, including beat-to-beat BP,
electrocardiographically deduced heart rate and impedance cardiography, was
performed during a 30 min baseline and continued up to 120 min after glucose
ingestion. Blood samples were taken at baseline, 30, 60, 90, and 120 min for
the assessment of glucose, insulin and c-peptide. Additionally, we evaluated body
composition by using validated bioelectrical impedance techniques.
Results: Individual overall changes (i.e., averages over 120min) for systolic BP ranged
from −4.9 to +4.7mmHg, where increases and decreases were equally distributed
(50%). Peak changes (i.e., peak averages over 10min intervals) for systolic BP ranged
from −1.3 to +9.5mmHg, where 93% of subjects increased systolic BP above baseline
values (similar for diastolic BP) whilst 63% of subjects increased peak systolic BP by
more than 4mmHg. Changes in peak systolic BP were negatively associated with the
calculated Matsuda-index of insulin sensitivity (r = −0.39, p = 0.04) but with no other
evaluated parameter including body composition. Moreover, besides a trend toward
an association between overall changes in systolic BP and total fat mass percentage
(r = +0.32, p = 0.09), no association was found between other body composition
parameters and overall BP changes.
Conclusion: Substantial inter-subject variability in BP changes was observed in a
healthy, non-obese subpopulation in response to an oral glucose load. In 63% of
subjects, peak systolic BP increased by more than a clinically relevant 4mmHg. Peak
systolic BP changes, but not overall BP changes, correlated with insulin sensitivity, with
little influence of body composition.
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INTRODUCTION
Cardiovascular disease (CVD) is one of the leading causes of
morbidity and mortality in European and many other countries
worldwide (Santulli, 2013). In this context, a leading risk factor
for CVD mortality is high blood pressure (BP), which accounts
for > 40% of CVD-related deaths worldwide (Danaei et al.,
2014). In individuals with type 2 diabetes mellitus (T2DM),
elevated BP further increases the risk of CVD (Turner et al.,
1993), whilst T2DM itself imposes a risk of coronary heart disease
mortality equivalent to that of a prior myocardial infarction
(Juutilainen et al., 2005). Moreover, a recent study confirmed
a time dependent and additive effect of BP and increasing
blood glucose levels on the development of T2DM complications
(Stratton et al., 2006). It is noteworthy that even a state of
impaired glucose tolerance, a condition that usually precedes
T2DM, substantially elevates the risk for CVD (DeFronzo and
Abdul-Ghani, 2011). Therefore, the possibility arises that even
early stage perturbations in glucose metabolism may affect the
cardiovascular system.
It is generally agreed that in response to glucose ingestion
the resulting increase in blood glucose levels induces a rapid
increase in plasma insulin, which dose-dependently increases
cardiac output (by increasing stroke volume and heart rate)
and attenuates systemic vascular resistance (Baron and Brechtel,
1993). In this context, the decrease in vascular resistance is the
driving force for increases in stroke volume and heart rate in
order to counterbalance a potential drop in BP. This assertion
is supported by previous findings from our group, which show
increased heart rate, stroke volume, cardiac output, and double
product (as a marker of cardiac oxygen demand Van Vliet and
Montani, 1999) in response to glucose ingestion, whilst total
peripheral resistance was found to decrease (Brown et al., 2008a;
Grasser et al., 2014); these effects being accompanied by either no
change (Brown et al., 2008a), or a small increase in BP (Grasser
et al., 2014).
Recognized as a standard diagnostic test for glucose
intolerance and diabetes, the oral-glucose-tolerance-test (OGTT)
is a simple method that provides pertinent information on
individual glucose metabolism. Despite the abundance of
information available on glucose and insulin responses to an
OGTT, little is known about concomitant changes in BP. In
young and healthy adults, ingestion of a glucose containing drink,
in opposition to fructose, has repeatedly been shown to have
little impact on postprandial systolic- and diastolic BP (Brown
et al., 2008a; Grasser et al., 2014) although a retrospective analysis
revealed a large inter-subject variability in the response to glucose
ranging from −2.3 to +8.3mmHg (averaged response over 60
min post-drink after subtracting baseline values) (Grasser et al.,
2014), an observation, which, to our best knowledge, has not yet
been prospectively investigated. Moreover, the factors underlying
the effect of this potential inter-subject variability in BP in
response to glucose remain elusive. One potential explanation
could be that this inter-subject variability is the result of altered
insulin action, which may perturb BP regulation.
We hypothesized firstly (i) that postprandial BP regulation
in response to a standardized glucose load exhibits substantial
inter-subject variability and, secondly, (ii) that these BP responses
are affected by accompanied glycemic responses. Therefore, we
evaluated, in 30 healthy male, non-obese adults, beat-to-beat
cardiovascular and glycemic blood parameter responses to a
standardized 75 g oral glucose drink. Additionally, and given the
important influence of body composition on the cardiovascular
and metabolic systems, we evaluated anthropometric and
adiposity parameters in order to explore their potential
association with overall and peak changes in BP.
MATERIALS AND METHODS
Subjects
Study participants were recruited from the university population
and surrounding institutions through advertisements. All
subjects completed a medical questionnaire, a dietary intake
questionnaire (including caffeine, caffeinated soft drinks and
alcohol habits), and had a physical exam to ensure their suitability
for inclusion in the study. Subjects recruited to the study were
familiarized with all cardiovascular monitoring equipment and
experimental procedures to avoid possible period effects. Subjects
were considered eligible for inclusion if they were healthy, non-
smokers, Caucasian men, 165–200 cm in height, 20–45 years old
with a body mass index (BMI) ranging from 18.5 to 29.9 kg/m2.
Exclusion criteria included any medical condition that could
interfere with the measured variables, e.g., cardiovascular-,
gastrointestinal-, neurological-, and overt metabolic disorders.
Moreover, subjects taking medication (either for acute or chronic
illnesses), competition athletes, smokers, overtly sedentary, those
with a fear of needles or who had in the past adverse reactions
to cannulation were excluded. Finally, participants diagnosed
with T2DM based on the following criteria in response to the
OGTT were excluded: showing either (a) fasting glucose levels
≥7.0mmol/L (126mg/dL) (American Diabetes Association,
2009), or (b) 2-h glucose ≥ 11.1mmol/L (200mg/dL) (American
Diabetes Association, 2009). Written informed consent to
participate in the study was obtained from all subjects prior to
their first test. The study protocol complied with the Declaration
of Helsinki and received ethical approval from the Commission
cantonale d’éthique de la recherche sur l’être humain (Canton de
Vaud, Switzerland).
Study Design
All experiments took place in a quiet, temperature-controlled
(22 ± 1◦C) laboratory and started at 08.00 a.m. following a
12-h overnight fast. Subjects were requested to avoid alcohol,
caffeine and physical activity for 24 h prior to the test, and
to use public transportation to arrive to the laboratory on the
morning of the experiment. On arrival to the laboratory, subjects
were asked to empty their bladders if necessary and to sit in
a comfortable armchair. Electrocardiography (ECG)/Impedance
electrodes were positioned together with upper arm and BP cuffs
placed on the fingers. Electrode strips were placed at the neck
and thoracic regions; the latter specifically at the mid-clavicular
at the xiphoid process level (Grasser et al., 2009) and an 18-gauge
1.3 × 33-mm one-way Teflon catheter was inserted in the left
cubital vein (not possible in one subject). Following a variable
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period for attainment of cardiovascular and metabolic stability
(approximately 30 min), a baseline recording was then made for
30 min. Following this, a baseline blood sample (10mL) was
drawn, which was followed by ingestion of the glucose drink
[75 g of anhydrous D-glucose, dissolved in 300mL water at room
temperature (22◦C)] over 4 min. Cardiovascular recordings then
continued for another 120 min and blood samples (10mL,
respectively) were drawn every 30 min thereafter, for up to 120
min post-drink. In order to avoid boredom during the study,
subjects were allowed to watch documentaries on a TV screen
placed in front of them.
Cardiovascular Measurements
A Task Force Monitor (CNSystems, Medizintechnik, Graz,
Austria) was used to measure hemodynamic changes over time
(systolic BP, diastolic BP, RR-interval (RRI), and stroke volume)
(Girona et al., 2014). Data were sampled at a rate of 1,000
Hz and stored on a hard disc for later analysis. Continuous
BP monitoring followed the Penaz principle from either the
index or middle finger of the right hand and was calibrated
to oscillometric brachial BP measurements on the contralateral
arm without perturbations caused by the calibration signal
(Gratze et al., 1998). We used height-adjustable tables for
reliable horizontally aligned placement of BP cuffs, i.e., table
heights were adjusted to the height of the right atrium (forth-
intercostal space), in order to avoid misleading BP readings
based on deviations from heart level. Moreover, an adaptive
cushion was placed on top of each table where the subject’s
forearms rested comfortably throughout the study. BP cuff sizes
were chosen according to the upper arm circumference. Cardiac
stroke volume, Heather index (a marker for positive inotropy
of the heart), and thoracic fluid volume were derived through
impedance cardiography measurements (Hill and Merrifield,
1976; Sherwood et al., 1998). Impedance cardiography, in which
changes in thoracic impedance are converted to reflect changes in
thoracic fluid content/volume over time, were performed based
on the original Kubicek (Kubicek et al., 1970) approach, but using
an improved estimate of thoracic volume (Fortin et al., 2006).
Blood Sample Measurements
Each blood collection comprised an initial 1mL blood draw,
which was immediately discarded due to clotting, and a
subsequent 10mL blood sample, which was used for analysis.
Samples were collected in appropriate K2E (EDTA) BD
vacutainers (Becton, Dickinson Allschwil, Switzerland) and were
processed and centrifuged according to the manufacturer’s
instructions to separate plasma from whole blood. Aliquots were
stored in 2ml cryovials and plasma samples for glucose analysis
were immediately frozen and stored at −80◦C; plasma samples
for the analysis of insulin and C-peptide were stored at −20◦C.
After thawing the samples, assays were performed according
to the manufacturer’s instructions (SystemRoche/Hitachi cobas,
Roche Diagnostics, Basel, Switzerland): (i) Glucose by the
reference method with hexokinase Glucose HK Gen.3 (cobas c
501, Roche Diagnostics); (ii) C-peptide by ECLIA technology
(cobas e 601, Roche Diagnostics). Insulin was measured by
using an ELISA assay kit (Mercodia, Uppsala, Sweden) in
accordance with the manufacturer’s instructions. Phlebotomy
and blood sample processing were carried out in accordance
with institutional safety requirements for the handling of human
biological specimens.
Anthropometric and Body Composition
Measurements
Anthropometric measurements included (i) standing height
using a mechanical column scale with integrated stadiometer
(Seca model 709, Hamburg, Germany) and (ii) body weight
using an electronic scale (Tanita Corporation, Amsterdam, The
Netherlands). Body mass index was calculated as the ratio
of weight (kg) and height squared (m2). Waist circumference
(WC) was measured in a standing position using a non-stretch
tape. Body composition was measured using two devices: (i)
multi-frequency bioelectrical impedance analyzer (BIA; Inbody
720, Biospace Co., Ltd, Seoul, Korea) for the assessment of
total fat mass (percentage and kg), fat free mass (kg), skeletal
muscle mass (kg) and (ii) a dual-frequency BIA device (ViScan
AB-140, Tanita) for the assessment of trunk (abdominal) fat
percentage (Hunma et al., 2016). The ViScan technique has been
validated against magnetic resonance imaging for the prediction
of abdominal fat percentage (Browning et al., 2010).
Data Collection/Processing
Beat-to-beat values of RRI, heart rate, systolic BP and diastolic
BP, stroke volume, cardiac output, total peripheral resistance,
Heather index, double product, and thoracic fluid content were
averaged every 10 min during baseline and every 10 min during
the 120 min post-drink period. Overall changes were calculated
as averages over the entire 120 min measurement period with
baseline values subtracted. To derive peak changes, changes over
the 120 min measurement period were divided into 12 × 10
min averages and the maximum response in any one of these
10 min average intervals was taken as the peak change. Heart
rate was calculated from the appropriate RRI. Cardiac output was
computed as the product of stroke volume and heart rate. Total
peripheral resistance was calculated as [mean BP/cardiac output],
where mean BP was calculated from diastolic BP and systolic BP
as follows: [mean BP = diastolic BP + 1/3 (systolic BP-diastolic
BP)]. Double product was calculated as [heart rate× systolic BP].
Homeostatic model assessment for insulin resistance (HOMA-
IR) was calculated as [fasting glucose (mmol/L)× fasting insulin
(mIU/L)]/22.5 (Matthews et al., 1985) and the Matsuda-Index
of insulin sensitivity (ISI-Mat) as [10,000/square root of (fasting
glucose × fasting insulin) × (mean glucose × mean insulin
during OGTT)] (Matsuda and DeFronzo, 1999).
Statistical Analysis
Statistical analyses were performed using statistical software: (i)
Statistix version 8.0, Analytical Software, St. Paul, MN, USA
and (ii) GraphPad Prism, Version 6, GraphPad Software, Inc.,
La Jolla, USA. All values were reported either as means ± SD
(Table 1) or as medians with or without (Figures 1–4) range and
the corresponding upper and lower 95% confidence intervals
(CI). Testing for normal distribution was performed using
the D’Agostino & Pearson omnibus normality test. Repeated
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TABLE 1 | Resting baseline subject characteristics.
Variable Mean ± SD Min–Max n
Fasting glucose, mmol/L 5.1 ± 0.3 4.3–5.9 29
Fasting insulin, mIU/L 4.8 ± 3.4 0.5–14.3 29
Fasting C-peptide, nmol/L 0.86 ± 0.22 0.53–1.37 28
HOMA-IR, AU 1.1 ± 0.8 0.1–3.6 29
Age, years 23.5 ± 3.3 20–33 30
Weight, kg 77 ± 12 57–104 30
Height, cm 178 ± 8 166–197 30
Body Mass Index, kg/m2 24.2 ± 3.0 18.9–29.8 30
Waist circumference, cm 86 ± 9 74–103 30
Total fat mass, % 16.4 ± 4.8 7.8–26.1 29
Total fat mass, kg 13.1 ± 5.6 5.2–25.1 29
Total trunk fat, % 19.8 ± 7.6 5.0–35.4 30
Total fat free mass, kg 64 ± 8 49–81 29
Skeletal muscle mass, kg 37 ± 5 27–46 29
Systolic blood pressure, mmHg 114 ± 6 104–129 30
Diastolic blood pressure, mmHg 73 ± 5 65–82 30
Heart rate, beats/min 65 ± 8 51–83 30
Stroke volume, mL 82 ± 14 53–115 30
Cardiac output, L/min 5.3 ± 0.6 3.5–6.1 30
Total peripheral resistance, mmHg/min/L 16.7 ± 2.4 13.5–24.0 30
Heather index, 1/s2 0.23 ± 0.04 0.10–0.30 30
Double product, mmHg/beats/min 7385 ± 1066 5656–9915 30
Thoracic fluid content, k−1 32 ± 5 25–49 30
Values were obtained during the resting baseline measurement period prior to subjects
undergoing the oral glucose tolerance test. Values are derived from fasting blood samples.
SD, standard deviation; Min, minimum value; Max, maximum value; n, number of subjects;
HOMA-IR, homeostatic model assessment of insulin resistance; AU, arbitrary units.
measures ANOVA with Dunnett’s multiple comparison post-
hoc testing or the Friedman test with Dunns post-hoc testing
was used to test for changes over time from baseline level (left
panels Figures 1–4). Pearson correlation analysis was used to
assess associations between overall and peak changes in systolic-
and diastolic BP (dependent variables) and other concurrently
assessed anthropometric-, blood-, and cardiovascular variables
(Tables 2, 3). Pearson’s r statistic is used to determine the effect
size when two variables are continuous and when there is only
one group (i.e., no separate intervention and control) (Nakagawa
and Cuthill, 2007). Given that both variables (BP and fat mass)
were continuous and that the study did not have separate groups,
Pearson’s correlation was used as an index of effect size to support
the statement of a trend throughout the manuscript. All reported
p-values are two-sided and significance was set at p< 0.05.
RESULTS
Baseline Characteristics
A total of 30 healthy, Caucasian male subjects were included in
this study. Baseline resting blood sample -, anthropometric-, and
cardiovascular data prior to undergoing OGTT are presented
in Table 1. None of the subjects presented with T2DM,
hypertension, or obesity (Table 1).
Cardiovascular Variables–Overall Time
Course Changes
In response to OGTT, overall time course changes for systolic
BP and diastolic BP did not change significantly over the entire
observation period (Figure 1, left panels). By contrast, there was
a gradual, significant increase in heart rate, with peak responses
observed around 80 min post-drink (5.4± 2.7 beats/min), which
plateaued thereafter (Figure 1, left panels). Stroke volume and
cardiac output increased significantly following ingestion of the
glucose drink; stroke volume peaked around 40 min post-drink
(5.2 ± 5.8 ml) and returned afterwards slowly toward baseline,
whilst cardiac output responses continued to plateau until the
end of the study period (Figure 2, left panels). Total peripheral
resistance decreased significantly during OGTT and was found
to be a negative mirror image of cardiac output with a gradual
decrease below baseline levels soon after glucose ingestion. This
negative total peripheral resistance response was maintained
for the entire study period (Figure 2, left panels). Soon after
glucose ingestion, Heather index and double product began to
increase above baseline values and plateaued thereafter; double
product responses were more gradual than those of Heather
index (Figure 3, left panels). On the other hand, thoracic fluid
content increased gradually, reached significance after 80 min
and peaked around 110 min post-drink (0.37 ± 0.57 k−1)
(Figure 3, left panel).
Cardiovascular Variables–Individual Overall
and Peak Changes
Individual overall changes ranged from +0.3 to +7.5 beats/min
(Median: +3.6; 95% CI from +2.7 to +4.8 beats/min) for heart
rate, from−4.9 to+4.7mmHg (Median:+0.0; 95%CI from−0.8
to +1.5mmHg) for systolic BP, and from −4.5 to +2.8mmHg
(Median: −0.4; 95% CI from −1.9 to +0.2mmHg) for diastolic
BP (Figure 1, right panels). Individual overall changes ranged
from −8.2 to +8.8ml (Median: +3.2; 95% CI from +2.3
to +3.9ml) for stroke volume, from −0.44 to +0.92 L/min
(Median:+0.48; 95% CI from+0.39 to+0.79 L/min) for cardiac
output, and from −3.3 to +1.8mmHg/min/L (Median: −1.7;
95% CI from −1.9 to −1.5mmHg/min/L) for total peripheral
resistance (Figure 2, right panels). Finally, individual overall
changes ranged from −0.03 to +0.08 1/s2 (Median: +0.03; 95%
CI from +0.03 to +0.04 1/s2) for Heather index, from −178 to
+970mmHg/beats/min (Median: +409; 95% CI from +298 to
+611mmHg/beats/min) for double product, and from −0.47 to
+0.69 k−1 (Median: 0.15; 95% CI from +0.01 to +0.30 k−1)
for thoracic fluid content (Figure 3, right panels).
Individual peak changes ranged from+3.3 to+14.1 beats/min
(Median: +7.1; 95% CI from +6.3 to +9.4 beats/min) for HR,
from −1.3 to +9.5mmHg (Median: +4.8; 95% CI from +2.4
to +5.2mmHg) for systolic BP, and from −0.9 to +7.0mmHg
(Median: +9.0; 95% CI from +5.3 to +10.2mmHg) for diastolic
BP (Figure 1, right panels). Individual peak changes ranged
from −0.4 to +18.4 ml (Median: +3.2; 95% CI from +2.3
to +3.9ml) for SV, from −0.12 to +2.08 L/min (Median:
+0.91; 95% CI from +0.64 to +1.07 L/min) for cardiac output,
and from −2.6 to +3.3 mmHg/min/L (Median: −0.33; 95%
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FIGURE 1 | (A–C): Time course of changes (1) from baseline in systolic blood pressure (SBP), diastolic blood pressure (DBP), and heart rate (HR), respectively.
Closed circles (•) represent averaged beat-to-beat data over 10 min intervals, which were subtracted from each baseline level and presented as deltas. Data recorded
during the 4 min glucose ingestion period were excluded from the analysis, and Time 0 denotes the resumption of continuous cardiovascular measurements after
subjects have finished the oral glucose drink. (D–F) represent overall (i.e., averages over 120 min with baseline values subtracted) changes in SBP, DBP, and HR
relative to baseline. (G–I) represent peak (i.e., derived from the maximum response averaged over a 10 min interval) changes in SBP, DBP, and HR relative to baseline.
**P < 0.01 and ***P < 0.005 represent statistically significant differences over time from baseline values (left). values are reported as means ± SD, whilst right data are
presented as a scatter dot plot with a median (bold horizontal dashed line).
CI from −0.24 to −0.54mmHg/min/L) for total peripheral
resistance (Figure 2, right panels). Finally, individual peak
changes ranged from +0.00 to +0.16 1/s2 (Median: +0.06; 95%
CI from +0.05 to +0.08 1/s2) for Heather index, from +417 to
+1,998mmHg/beats/min (Median: +1,090; 95% CI from +754
to +1,314 mmHg/beats/min) for double product, and from
+0.02 to +1.89 k−1 (Median: +0.46; 95% CI from +0.28 to
+0.76 k−1) for thoracic fluid content (Figure 3, right panels).
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FIGURE 2 | (A–C): Time course of changes (1) from baseline in stroke volume (SV), cardiac output (CO) and total peripheral resistance (TPR), respectively. Closed
circles (•) represent averaged beat-to-beat data over 10 min intervals, which were subtracted from each baseline level and presented as deltas. Data recorded during
the 4 min glucose ingestion period were excluded from the analysis, and Time 0 denotes the resumption of continuous cardiovascular measurements after subjects
have finished the oral glucose drink. (D–F) represent overall (i.e., averages over 120 min with baseline values subtracted) changes in SV, CO, and TPR relative to
baseline. (G–I) represent peak (i.e., derived from the maximum response averaged over a 10 min interval) changes in SV, CO, and TPR relative to baseline. **P < 0.01
and ***P < 0.005 represent statistically significant differences over time from baseline values (left). Left values are reported as means ± SD, whilst right data are
presented as a scatter dot plot with a median (bold horizontal dashed line).
Blood Sample Variables–Overall Time
Course Changes and Individual Responses
In response to OGTT, glucose and insulin increased significantly
above baseline levels and peaked around 30 min post-
drink (Glucose: +8.4 ± 1.3mmol/L, +6.2 to +10.6 (min
to max)mmol/L; Insulin: +64 ± 29 mIU/L, +26 min to
+124 max mIU/L). C-peptide increased gradually and
significantly above baseline levels, and peaked around 60
min post-drink (+3.6 ± 0.8 nmol/L +1.2 to +4.3 (min
to max) nmol/L), plateauing thereafter (Figure 4, left
panels).
Individual overall changes ranged from +18 to
+500mmol/L/h (Median: +230; 95% CI from +202 to
+287 mmol/L/h) for glucose, from +2,075 to +12,870mIU/L/h
(Median: +5,205; 95% CI from +3,884 to 6,042 mIU/L/h) for
insulin, and from +144 to +410 nmol/L/h (Median: +260; 95%
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FIGURE 3 | (A–C): Time course of changes (1) from baseline in Heather index (HI), rate pressure double product (DP), and thoracic fluid content (TFC), respectively.
Closed circles (•) represent averaged beat-to-beat data over 10 min intervals, which were subtracted from each baseline level and presented as deltas. Data recorded
during the 4 min glucose ingestion period were excluded from the analysis, and Time 0 denotes the resumption of continuous cardiovascular measurements after
subjects have finished the oral glucose drink. (C–E) represent overall (i.e., averages over 120 min with baseline values subtracted) changes in HI, DP, and TFC relative
to baseline. (E–G) represent peak (i.e., derived from the maximum response averaged over a 10 min interval) changes in HI, DP, and TFC relative to baseline. *P <
0.05, **P < 0.01 and ***P < 0.005 represent statistically significant differences over time from baseline values (left). Left values are reported as means ± SD, whilst
right data are presented as a scatter dot plot with a median (bold horizontal dashed line).
CI from +226 to +276 nmol/L/h) for C-peptide (Figure 4, right
panels).
Linear Correlation Analysis
Overall changes in systolic BP correlated with overall changes in
diastolic BP (r: +0.70, p < 0.005) and double product (r: +0.58,
p < 0.005), but not with glycemic parameters (Table 2). Aside
from a trend toward a significant association with total fat mass
[%] (r: +0.32, p = 0.09), overall changes in systolic BP did
not correlate with anthropometric parameters (Table 2). Overall
changes in diastolic BP correlated positively with overall changes
in double product (r: +0.43, p = 0.02), but with no other
parameter (Table 2).
Peak changes in systolic BP correlated with peak changes in
diastolic BP (r: +0.62, p < 0.005) and weakly with the ISI-Mat
(r: −0.39, p = 0.04), but not with other glycemic parameters
(Table 3). Peak changes in diastolic BP did not correlate with any
investigated parameter (Table 3).
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FIGURE 4 | (A–C): Time course of changes (1) from baseline in blood
glucose, insulin and C-peptide levels, respectively. Closed circles (•) represent
averaged data from the respective blood-draw interval, i.e., at baseline, which
is denoted as 0, and every 30 min thereafter up to 120 min. (D–F) Represent
area under curve analysis using the trapezoid method for glucose (D), insulin
(E) and C-peptide (F). ***P < 0.005 represents statistically significant
differences over time compared to baseline values (left). (A–C) Values are
reported as means ± SD, whilst (D–F) data are presented as a scatter dot plot
with a median (bold horizontal dashed line).
DISCUSSION
Tightly controlled human studies on BP changes in response
to glucose drinks are scarce and the factors underlying how
glucose ingestion could affect BP regulation are not fully
understood. Therefore, we evaluated continuously beat-to-beat
cardiovascular and glycemic blood parameter responses to a
standardized 75 g oral glucose drink. Additionally, and given the
important influence of body composition on the cardiovascular
and metabolic system, we evaluated anthropometric and
adiposity parameters in order to explore their potential
association with overall and peak changes in BP. We clearly
TABLE 2 | Pearson correlation analysis of the association between overall blood
pressure responses to OGTT and other measured variables.
1 SBP 1 DBP
r p n r p n
HOMA-IR −0.12 0.55 29 −0.21 0.28 29
Fasting glucose +0.22 0.26 29 −0.02 0.91 29
Fasting insulin −0.13 0.50 29 −0.20 0.29 29
Fasting C-peptide −0.02 0.92 28 −0.12 0.55 28
ISI-Mat −0.11 0.58 29 +0.07 0.73 29
Body Mass Index +0.14 0.45 30 −0.14 0.45 30
WC +0.24 0.20 30 −0.04 0.85 30
Total fat mass, % +0.32 0.09 29 −0.09 0.64 29
Total fat mass, kg +0.29 0.12 29 −0.09 0.65 29
Fat free mass +0.03 0.87 29 −0.07 0.73 29
Fat mass index +0.27 0.15 29 −0.13 0.51 29
Fat free mass index −0.10 0.62 29 −0.20 0.30 29
SMM +0.02 0.92 29 −0.09 0.65 29
Total trunk fat +0.27 0.15 29 −0.01 0.95 29
1 Systolic BP – – 30 +0.70 < 0.005*** 30
1 Diastolic BP +0.70 < 0.005*** 30 – – 30
1 Heart rate +0.03 0.88 30 +0.06 0.77 30
1 Stroke volume −0.10 0.59 30 −0.12 0.54 30
1 Cardiac output −0.12 0.54 30 −0.10 0.58 30
1 TPR +0.22 0.25 30 +0.25 0.18 30
1 Double product +0.58 < 0.005*** 30 +0.43 0.02* 30
1 Heather index −0.10 0.60 30 −0.11 0.55 30
Values are derived from a Pearson linear correlation analysis between overall systolic
(1 SBP) (i.e., averaged response over 120 min with fasting baseline values subtracted)
and diastolic blood pressure (1 DBP) responses and blood-, anthropometric-, and
cardiovascular data obtained from healthy male adults who underwent an oral glucose
tolerance test (OGTT). r, correlation coefficient; n, number of subjects; HOMA-IR,
homeostatic model assessment of insulin resistance; ISI-Mat, Matsuda index of insulin
sensitivity; WC, waist circumference; SMM, skeletal muscle mass; BP, blood pressure;
TPR, total peripheral resistance; p < 0.05 was considered a statistically significant
association between independent and dependent variables.
observed a divergent effect of glucose with substantial inter-
subject variability for overall systolic BP measurements where
50% of subjects either increased or decreased BP in response
to glucose ingestion with an effect of insulin sensitivity or
body composition. With respect to peak changes in systolic BP,
however, the aforementioned two-face scenario was no longer
present, but rather a prevailing increase in BP where 63%
increased peak systolic BP by more than a clinically relevant
4mmHg; a potential effect of insulin sensitivity was observed, but
not body composition. Therefore, our data provide evidence that
glucose ingestion substantially elevates systolic BP over a short
period of time, a response that is weakly associated with insulin
sensitivity but not with body composition parameters.
Despite accumulating scientific evidence from cross-sectional
studies (Brown et al., 2011) and randomized controlled trials
(Raben et al., 2002) regarding the potential impact of chronic
consumption of sugar-sweetened beverages on BP, the underlying
mechanisms for the impact of sugary drinks on BP regulation
remain elusive. The notion was put forward more than a
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TABLE 3 | Pearson correlation analysis of the association between peak blood
pressure responses to OGTT and other measured variables.
1 Peak SBP 1 Peak DBP
r p n r p n
HOMA-IR +0.00 0.98 29 −0.08 0.69 29
Fasting glucose +0.09 0.64 29 +0.04 0.85 29
Fasting insulin +0.02 0.91 29 −0.06 0.76 29
Fasting C-peptide +0.06 0.77 28 +0.01 0.95 28
ISI-Mat −0.39 0.04* 29 −0.12 0.53 29
Body Mass Index +0.10 0.59 30 −0.11 0.57 30
WC +0.19 0.31 30 +0.04 0.83 30
Total fat mass, % +0.27 0.16 29 −0.05 0.81 29
Total fat mass, kg +0.19 0.33 29 −0.08 0.68 29
Fat free mass −0.05 0.78 29 −0.06 0.75 29
Fat mass index +0.18 0.34 29 −0.12 0.52 29
Fat free mass index −0.20 0.29 29 −0.29 0.13 29
SMM −0.05 0.76 29 −0.08 0.68 29
Total trunk fat +0.11 0.56 29 +0.02 0.91 29
1 Systolic BP – – 30 +0.62 < 0.005*** 30
1 Diastolic BP +0.62 < 0.005*** 30 – – 30
1 Heart rate +0.11 0.56 30 +0.04 0.83 30
1 Stroke volume −0.26 0.17 30 −0.28 0.14 30
1 Cardiac output −0.06 0.75 30 −0.13 0.50 30
1 TPR +0.14 0.45 30 +0.19 0.31 30
1 Double product +0.36 0.053 30 0.21 0.26 30
1 Heather index −0.10 0.61 30 −0.15 0.43 30
Values are derived from a Pearson linear correlation analysis of peak (i.e., derived from
the maximum response averaged over a 10 min interval with fasting baseline values
subtracted) systolic (1 Peak SBP) and diastolic blood pressure (1 Peak DBP) responses
and blood-, anthropometric-, and cardiovascular data obtained from healthy male adults
who underwent an oral glucose tolerance test (OGTT). r, correlation coefficient; n, number
of subjects; HOMA-IR, homeostatic model assessment of insulin resistance; ISI-Mat,
Matsuda index of insulin sensitivity; WC, waist circumference; SMM, skeletal muscle
mass; BP, blood pressure; TPR, total peripheral resistance; p < 0.05 was considered
as a statistically significant association between independent and dependent variables.
decade ago that repeated acute increases in BP, evoked by a
postprandial state due to the ingestion of sugary beverages,
could predispose to the development of CVD (Dickinson and
Brand-Miller, 2005). In randomized controlled trials, it has
repeatedly been shown that fructose, but not glucose or sucrose,
increased BP in healthy young adults (Brown et al., 2008a;
Grasser et al., 2014). Moreover, the glucose moiety of sucrose
seems to potentially counteract fructose-induced increases in BP
(Grasser et al., 2014). However, the notion that glucose does not
affect BP stands in contrast to findings from a cross-sectional
study where direct associations of glucose intake with BP were
observed (Brown et al., 2011). In addition to the limitations of
interpreting findings from such cross-sectional studies (Carlson
and Morrison, 2009), another potential explanation for the
observed difference could be the large inter-subject variability,
where subjects either increase or decrease BP in response to
a glucose-containing drink. Indeed, a post-hoc analysis of data
from a previously published randomized controlled trial found
substantial inter-subject variability in the BP response to glucose
ranging from −2.3 to +8.3mmHg (averaged over 60 min
post-drink after subtracting baseline values) (Grasser et al., 2014).
Notwithstanding the lack of significant overall change in systolic
BP and diastolic BP in response to glucose ingestion, our present
study observed a large inter-subject variability in overall and
peak (as a surrogate of treatment-induced changes of short-
term BP variability Mancia, 2012) BP changes, which contributes
to the growing scientific evidence on reproducible systolic BP
changes in humans. Moreover, 63% increased peak systolic BP
by more than 4 mmHg. Similar findings were observed, but
to a lesser degree, for overall and peak diastolic BP changes.
Our findings emphasize the importance of focusing on inter-
subject variability, rather than on mean results, in order not
to neglect potential treatment responders. In the context of
such treatment responders, our reported BP findings here in
response to a standardized glucose ingestion could have potential
implications for the development of a screening tool where
susceptible individuals are followed over a longer period of time
in order to monitor the potential emergence of hypertension.
It is worth mentioning that impaired glucose tolerance, a
condition that usually precedes T2DM, substantially elevates the
risk of CVD (DeFronzo and Abdul-Ghani, 2011). Therefore,
the possibility arises that even early stage perturbations in
glucose metabolism may affect the cardiovascular system and
that glycemic changes in response to a glucose drink could affect
BP regulation. In contrast to the impact of insulin on total
peripheral resistance and cardiac output in response to glucose
ingestion in normal glucose tolerance, it is suggested that in
a state of impaired glucose tolerance, which is characterized
by elevated resting insulin and sympathetic neural activity
(Rowe et al., 1981), an additional surge in insulin will further
raise sympathetic nerve activity and, therefore, impact on total
peripheral resistance (Ferrannini et al., 1997). In addition to
the contention by Ferrannini et al. (1997), which suggested that
insulin resistance could lead to a reduced vasodilator response
that in turn raises BP (Ferrannini et al., 1997), we speculate that a
state of impaired glucose tolerance proportionately affects cardiac
parameters, i.e., heart rate and inotropy, to a greater extent than
the vasodilatory effects. This could, in turn, raise BP due to
the augmented effect of a raised sympathetic tone on cardiac
cells rather than on peripheral vasodilation. Further studies are
warranted to investigate this important contention in light of the
fact that T2DM etiology has frequently been associated with the
emergence of hypertension.
Using an OGTT in order to investigate a potential association
between insulin and BP, Haffner et al. (2002) observed a weak
relationship between fasting glycemic parameters (insulin and
HOMA IR) and BP, which were similar between different
ethnicities. However, apart from a weak association (r = +0.39)
between peak changes in systolic BP and ISI-Mat, as a measure
of insulin sensitivity (Matsuda and DeFronzo, 1999), we did not
observe any further association between glycemic parameters,
and indices of glucose metabolism (HOMA-IR), with overall and
peak changes in systolic BP. Our findings are in agreement with a
previous study where variations in HOMA, as a marker of insulin
sensitivity, did not explain BP in men (Poirier et al., 2005). In this
context, the ISI-Mat has been shown to be a better predictor for
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the assessment of hypertension risk compared to the HOMA-IR
(Furugen et al., 2012). Moreover, Ferrannini (Ferrannini et al.,
1997) investigated, in non-diabetic men and women, the impact
of insulin resistance on BP parameters using an euglycemic
insulin clamp technique at physiological insulin concentrations
and observed in a lean subgroup an inverse association between
insulin sensitivity (M-value) and systolic BP, which is in line
with our findings. Taken together, our results suggest that in
healthy, non-obese, adult men, insulin sensitivity potentially
affects systolic BP, but not diastolic BP, in response to a glucose
drink.
Another potential contributor to increasing BP in humans
is the distribution of adipose tissue stores, where abdominal
adipose tissue in particular has been suggested to be a key
correlate of health risks associated with being overweight or obese
(Tchernof and Després, 2013). In a recent observational study,
where a hypothesized relationship between visceral adipose
tissue, quantified by a 1.5 T magnetic resonance imaging scanner,
and incident hypertension was investigated, increasing levels of
visceral fat were associated with increasing risk for emergence
of hypertension (Chandra et al., 2014). In our study, overall
and peak systolic and diastolic BP changes were not significantly
related to any body composition parameter investigated in this
study. However, total fat mass [%] and total trunk fat [%], which
has been validated against magnetic resonance imaging for the
prediction of abdominal fat percentage (Browning et al., 2010),
showed a trend toward a positive association with overall changes
in systolic BP (r=+0.32, p= 0.09). It is possible to speculate that
a larger sample size in our studymay have resulted in a significant
p-value along with an unchanged correlation coefficient (Altman
and Krzywinski, 2015).
This study has a number of caveats: firstly, (i) use of the
Task Force Monitor for BP and stroke volume measurements
was not validated in the current study. However, the continuous
non-invasive arterial BP technology integrated in the Task Force
Monitor has previously been validated against clinically invasive
gold standards and was found to be comparable in terms of
continuity, accuracy and waveform dynamics (Jeleazcov et al.,
2010; Ilies et al., 2012). A second potential limitation of the study
(ii) is the fact that recruitment was confined to a Caucasian
subpopulation in order to avoid potential confounding as a
result of ethnic differences in the OGTT response (Sleddering
et al., 2014), which limits the generalizability of our findings.
Thirdly, (iii) the clinical significance and relevance of a short-
term 4 mmHg change in BP may be questioned. In this context,
even short-term elevations in BP, if repeated over a long time,
could have the potential to affect the cardiovascular system in a
cumulative fashion (Brown et al., 2008b). Moreover, a growing
body of literature exists on the vascular effects consequent to
T2DM (Montero et al., 2013; Tousoulis et al., 2013), therefore,
we deem any potential vascular effect of a glucose load to be
noteworthy. In this context, it is important to bear in mind
that prolonged sitting, which has previously been shown to be
associated with endothelial dysfunction (Restaino et al., 2016),
could be suggested to contribute to the variability in BP response
in our study where subjects sat continuously for > 3 h. In
FIGURE 5 | (A,B): Correlation analysis of overall (i.e., averages over 120 min with baseline values subtracted) changes in systolic (1 SBP) and diastolic blood pressure
(1 DBP) responses and body mass index. (C,D): Correlation analysis of peak (i.e., derived from the maximum response averaged over a 10 min interval) changes in
systolic (1 SBP) and diastolic blood pressure (1 DBP) responses and body mass index. Data derived from healthy male adults who underwent an oral glucose
tolerance test. n = number of subjects; r: correlation coefficient; p < 0.05 was considered as a statistically significant association between variables.
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addition, since gastric emptying accounts for up to 34% of
the variation in peak plasma glucose (Horowitz et al., 1993),
interindividual differences in gastric emptying in this study could
be suggested to account for some of the variability in the observed
BP response. A final caveat (iv) can be found in not separating
our cohort based on their body mass index in a normal weight
and an overweight group. However, our observed overall and
peak BP responses did not differ significantly (all p > 0.10)
between proposed groups when separated by body mass index,
i.e., Group A: Body mass index from 18.5 to 24.9 kg/m2 (mean:
22.5 ± 1.6 kg/m2; n = 19) and Group B: Body mass index from
25.0 to 29.9 kg/m2 (mean: 27.3 ± 1.9 kg/m2; n = 11), therefore
we combined both groups for the final analysis. Moreover, no
significant association was observed for overall and peak changes
in BP and body mass index (Figures 5A–D). In this context,
the current study also did not include obese subjects. The lack
of correlation between systolic BP and body composition, as
well as the weak association with insulin sensitivity could have
been different in an obese group where a stronger correlation
between fat mass and insulin sensitivity would be expected based
on previous studies (McLaughlin et al., 2011). However, we
observed a trend toward an association between overall changes
in systolic BP and total fat mass in percentage (r = +0.32, p
= 0.09). Moreover, body fat mass in percentage and insulin
sensitivity correlated in our study (r = −0.59, p < 0.005), which
is in agreement with the findings by McLaughlin and colleagues
(McLaughlin et al., 2011).
In conclusion, our data show that ingestion of 75 g of glucose
elevates BP in a healthy non-obese population. We observed two
faces to the effect of glucose on BP: overall changes in systolic
BP were increased in half of the subjects, while in the other half,
overall changes were decreased. This divergent effect was not
observed for peak changes in systolic BP, which were increased
in > 90% of subjects in response to glucose ingestion. Changes
in BP do not appear to be dependent on body composition,
but may be influenced to some extent by insulin sensitivity.
In addition, a large variability in the response to glucose was
observed for all variables, whether directly or indirectly measured
or calculated. This large variability highlights the need for great
caution when interpreting the average findings from one single
study, particularly studies with small sample sizes. Further work
is required to identify factors associated with this variability in
the BP response to glucose ingestion and the potential influence
of insulin sensitivity.
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